TLR4 and colitis: It was recently shown that oral administration of high dosages of PGE2 can by-pass the protective effect exhibited by TLR4-deficient mice, which implicates PGE2 as an important TLR4 downstream molecule in colorectal cancer development as well as a potential target for more effective prevention of colitis-associated colorectal cancer [54].